1. Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge CB4 0WG, U.K.
2. Department of Veterinary Medicine, University of Cambridge, Cambridge CB3 0ES, U.K.
3. Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London SW7 2AZ, U.K.
4. Medical Mass Spectrometry Imaging, Department of Pharmaceutical Biosciences, Uppsala University, 751 24 Uppsala, Sweden
5. Science for Life Laboratory, Spatial Mass Spectrometry, Uppsala University, 751 24 Uppsala, Sweden
6. Division of Digestive Diseases, Section of Pathology, Imperial College London, St. Mary’s Hospital, London W2 1NY, U.K.
7. Department of Cellular Pathology, Charing Cross Hospital, London W6 8RF, U.K.
8. Biologics Engineering, R&D, AstraZeneca, Cambridge CB4 0WG, U.K.
9. BHF Centre for Cardiovascular Science, Queen’s Medical Research Institute, University of Edinburgh, Edinburgh EH16 4TJ, U.K.
10. National Centre of Excellence in Mass Spectrometry Imaging (NiCE-MSI), National Physical Laboratory, Teddington TW11 0LW, U.K.
11. Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8TA, U.K.